These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 38688945)

  • 21. TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.
    Chen Z; Cai H; Ye W; Wu J; Liu J; Xie Y; Feng S; Jin Y; Lv Y; Ye H; Cai C; Cai G
    Front Immunol; 2024; 15():1445472. PubMed ID: 39234254
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
    Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
    J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
    Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
    J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
    Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
    Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
    Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
    Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.
    Guo Y; Pan WK; Wang ZW; Su WH; Xu K; Jia H; Chen J
    Biomed Res Int; 2021; 2021():4532438. PubMed ID: 34917682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
    Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
    Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
    Ma B; Li H; Qiao J; Meng T; Yu R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing.
    Wang J; Sun HC; Cao C; Hu JD; Qian J; Jiang T; Jiang WB; Zhou S; Qiu XW; Wang HL
    Front Oncol; 2023; 13():1136729. PubMed ID: 37213285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-omic analysis and validation reveal ZBP1 as a potential prognostic and immunotherapy-related biomarker in head and neck squamous cell carcinoma.
    Li Y; Wang N; Yang G
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101901. PubMed ID: 38688403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
    Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
    Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel CAF-cancer cell crosstalk-related gene prognostic index based on machine learning: prognostic significance and prediction of therapeutic response in head and neck squamous cell carcinoma.
    Xu Y; Li J; Wang J; Deng F
    J Transl Med; 2024 Jul; 22(1):645. PubMed ID: 38982511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.